Somatostatin pp 313-317 | Cite as

Somatostatin and Upper Gastrointestinal Hemorrhage

  • Inger Magnusson
Part of the Serono Symposia, USA book series (SERONOSYMP)


Somatostatin is a potent inhibitor of gastric secretion of acid, gastrin, pepsin and intrinsic factor (1,2).


Placebo Group Duodenal Ulcer Gastric Ulcer Esophageal Varix Gastric Secretion 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schrumpf E, Vatn MH, Hanssen KF, Myren J. A small dose of somatostatin inhibits the pentagastrin stimulated gastric secretion of acid, pepsin and intrinsic factor in man. Clin Endocrinol (Oxf), 1978; 8: 391.CrossRefGoogle Scholar
  2. 2.
    Bloom SR, Mortimer CH, Thorner MO, et al. Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet 1974; 2: 1106.PubMedCrossRefGoogle Scholar
  3. 3.
    Johansson C, Aly A. Stimulation of gastric mucus output by somatostatin in man. Eur J Clin Invest 1982; 12: 37.PubMedCrossRefGoogle Scholar
  4. 4.
    Bosch J, Kravetz D, Rodes J. Effects of somatostatin on hepatic and systemic hemadynamics in patients with cirrhosis of the liver: comparison with vasopressin. Gastroenterology 1981; 80: 518.PubMedGoogle Scholar
  5. 5.
    Green FV, Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. Gastroenterology 1978; 74: 38.PubMedGoogle Scholar
  6. 6.
    Foster DN, Miloszewski KJA, Losowsky MS. Stigmata of recent haemorrhage in diagnosis and prognosis of upper gastrointestinal bleeding. Br Med J 1978; 1: 1173.PubMedCrossRefGoogle Scholar
  7. 7.
    Bornman PC, Theodorou NA, Shuttleworth RD, Essel HP, Marks IN. Importance of hypovolaemic shock and endoscopic signs in predicting recurrent haemorrhage from peptic ulceration: a prospective evaluation. Br Med J 1985; 291: 245.CrossRefGoogle Scholar
  8. 8.
    Magnusson I, Ihre T, Johansson C, Seligson U, Torngren S, Uvnas-Moberg K. Randomised double blind trial of somatostatin in the treatment of massive upper gastrointestinal haemorrhage. Gut 1985; 25: 221.CrossRefGoogle Scholar
  9. 9.
    Kayasseh L, Keller U, Gyr K, Stalder GE, Wall M. Somatostatin and cimetidine in peptic-ulcer haemorrhage. Lancet 1980; 1: 844.PubMedCrossRefGoogle Scholar
  10. 10.
    Coraggio F, Scarpato P, Spina M, Lombardi S. Somatostatin and ranitidine in the control of iatrogenic haemorrhage of the upper gastrointestinal tract. Br Med J 1984; 289: 224.CrossRefGoogle Scholar
  11. 11.
    Somerville KW, Henry DA, Davies JG, Hine KR, Hawkey CJ, Langman MJS. Somatostatin in the treatment of haematemesis and melaena. Lancet 1985; 1: 130.PubMedCrossRefGoogle Scholar
  12. 12.
    Kim B, Wright HK, Bordan D, Fielding LP, Swaney R. Risk of surgery for upper gastrointestinal haemorrhage: 1972 versus 1982. Am J Surg 1985; 149: 474.PubMedCrossRefGoogle Scholar
  13. 13.
    Griffiths WJ, Neumann DA, Welsh JD. The visible vessel as an indicator of uncontrolled or recurrent gastrointestinal haemorrhage. N Engl J Med 1979; 300: 1411.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Inger Magnusson
    • 1
  1. 1.Department of SurgeryKarolinska Institutet at SodersjukhusetStockholmSweden

Personalised recommendations